Breaking News Bar

Business News and Information

WeissLaw LLP Investigates Envision Healthcare Holdings Inc. Acquisition

NEW YORK, June 12, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Envision Healthcare Holdings Inc. ("EVHC" or the "Company") (NYSE: EVHC) in connection with the proposed acquisition of the Company by global investment firm KKR & Co L.P. ("KKR") (NYSE: KKR).  Under the terms of the agreement, EVHC shareholders will receive $46.00 in cash for each EVHC share they own. 

WeissLaw is investigating whether EVHC's Board acted to maximize shareholder value prior to entering into the agreement.  Notably, at least one analyst set a target price of $51.00 per share, or $5.00 above the offer price.  Additionally, EVHC shares traded for $57.30, or $11.30 above the offer price, less than a year ago in August of 2017. 

Given these facts, WeissLaw is investigating whether EVHC's Board acted in the best interests of EVHC's public shareholders to maximize shareholder value prior to entering into the agreement.  If you own EVHC shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin by telephone at (888) 593-4771 or by email at  

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at or fill out the form on our website,

Cision View original content:


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear